BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 24898425)

  • 21. Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa.
    Ishii T; Murakami J; Notohara K; Cullings HM; Sasamoto H; Kambara T; Shirakawa Y; Naomoto Y; Ouchida M; Shimizu K; Tanaka N; Jass JR; Matsubara N
    Gut; 2007 Jan; 56(1):13-9. PubMed ID: 16785283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma.
    Wong VC; Chan PL; Bernabeu C; Law S; Wang LD; Li JL; Tsao SW; Srivastava G; Lung ML
    Int J Cancer; 2008 Dec; 123(12):2816-23. PubMed ID: 18798555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
    Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
    Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.
    Zhu YH; Fu L; Chen L; Qin YR; Liu H; Xie F; Zeng T; Dong SS; Li J; Li Y; Dai Y; Xie D; Guan XY
    Cancer Res; 2013 Apr; 73(7):2298-309. PubMed ID: 23436800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
    Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
    Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer.
    Matsuzaki K; Deng G; Tanaka H; Kakar S; Miura S; Kim YS
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8564-9. PubMed ID: 16361538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite instability and clinicopathological features in esophageal squamous cell cancer.
    Matsumoto Y; Nagasaka T; Kambara T; Hoshizima N; Murakami J; Sasamoto H; Hosokawa M; Naomoto Y; Isozaki H; Shimizu K; Tanaka N; Matsubara N
    Oncol Rep; 2007 Nov; 18(5):1123-7. PubMed ID: 17914562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
    Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
    Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
    Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
    Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers.
    Oka D; Yamashita S; Tomioka T; Nakanishi Y; Kato H; Kaminishi M; Ushijima T
    Cancer; 2009 Aug; 115(15):3412-26. PubMed ID: 19472401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
    Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
    Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
    Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
    Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations.
    Saeki H; Kitao H; Yoshinaga K; Nakanoko T; Kubo N; Kakeji Y; Morita M; Maehara Y
    Clin Cancer Res; 2011 Apr; 17(7):1731-40. PubMed ID: 21325068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Shitara Y; Yoshikawa M; Tajima K; Masuda N; Shouji H; Tsukada K; Nakajima T; Kuwano H
    Cancer; 2000 Sep; 89(5):955-62. PubMed ID: 10964324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
    Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
    J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
    Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
    Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
    Mandelker DL; Yamashita K; Tokumaru Y; Mimori K; Howard DL; Tanaka Y; Carvalho AL; Jiang WW; Park HL; Kim MS; Osada M; Mori M; Sidransky D
    Cancer Res; 2005 Jun; 65(11):4963-8. PubMed ID: 15930319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
    Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
    Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.